health risks of semaglutide Semaglutide: What we know about safety and cancer risk Who Should Consider Semaglutide GLP-1?

The C18 column was equilibrated with aqueous sulfuric acid

Studies show that abruptly discontinuing GLP-1 therapy almost always results in rapid weight regainoften within weeks to monthsbecause your body's appetite-suppressing pathways slowly return to baseline

Jennifer Groh, PhD, professor of psychology and neuroscience at Duke University

Together, we can utilize the advantages of Wegovy for successful weight management

Understanding your genetic predispositions, combined with comprehensive clinical evaluation, can support a more informed conversation with your healthcare provider about semaglutide eligibility and whether alternative GLP-1 options or non-pharmacologic strategies may be better suited to your health profile and goals